Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.8%

1 terminated/withdrawn out of 26 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
8(42.1%)
Phase 2
7(36.8%)
Phase 4
3(15.8%)
Phase 3
1(5.3%)
19Total
N/A(8)
Phase 2(7)
Phase 4(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07487350Recruiting

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Role: collaborator

NCT04752592Not ApplicableCompleted

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

Role: collaborator

NCT05652400Active Not Recruiting

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia

Role: collaborator

NCT06352970Recruiting

Effects of Tuberculosis Infection on Development and Function of the Placenta

Role: collaborator

NCT06746350Not ApplicableNot Yet Recruiting

Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup

Role: lead

NCT03754322Not ApplicableCompleted

LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial

Role: collaborator

NCT06514560Recruiting

OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients

Role: collaborator

NCT05125380Not ApplicableUnknown

Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia

Role: collaborator

NCT05818059Not ApplicableUnknown

Active Close Contact Investigation of Tuberculosis Through Computer-aided Detection and Stool Xpert MTB/RIF Among People Living in Ethiopia

Role: collaborator

NCT03350048Completed

Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB

Role: collaborator

NCT03570814Phase 4Completed

Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Role: collaborator

NCT04847817Completed

Important Data on COVID-19 Profile in Africa

Role: collaborator

NCT04216420Not ApplicableCompleted

Electronic Pillbox-enabled SAT Versus DOT for TB Medication Adherence and Treatment Outcomes

Role: collaborator

NCT04241705Not ApplicableUnknown

Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia

Role: lead

NCT02308956Phase 3Completed

Task Sharing for the Care of Severe Mental Disorders in a Low-income Country

Role: collaborator

NCT02793388Phase 4Withdrawn

A Trial on Supervised Primaquine Use in Ethiopia

Role: collaborator

NCT01702974Phase 2Completed

Immune Reconstitution in HIV Disease (IREHIV)

Role: collaborator

NCT01698476Phase 2Completed

Immune Reconstitution in Tuberculosis Disease

Role: collaborator

NCT01524640Phase 4Completed

Bridging Study for Killed Oral Cholera Vaccine in Ethiopia

Role: collaborator

NCT00919776Phase 2Completed

Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum

Role: collaborator